218 related articles for article (PubMed ID: 16309172)
21. Modulation of paclitaxel resistance by annexin IV in human cancer cell lines.
Han EK; Tahir SK; Cherian SP; Collins N; Ng SC
Br J Cancer; 2000 Jul; 83(1):83-8. PubMed ID: 10883672
[TBL] [Abstract][Full Text] [Related]
22. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance.
Ranganathan S; Dexter DW; Benetatos CA; Chapman AE; Tew KD; Hudes GR
Cancer Res; 1996 Jun; 56(11):2584-9. PubMed ID: 8653701
[TBL] [Abstract][Full Text] [Related]
23. Non-adherent culture induces paclitaxel resistance in H460 lung cancer cells via ERK-mediated up-regulation of βIVa-tubulin.
Atjanasuppat K; Lirdprapamongkol K; Jantaree P; Svasti J
Biochem Biophys Res Commun; 2015 Oct; 466(3):493-8. PubMed ID: 26375501
[TBL] [Abstract][Full Text] [Related]
24. betaIII-tubulin is a multifunctional protein involved in drug sensitivity and tumorigenesis in non-small cell lung cancer.
McCarroll JA; Gan PP; Liu M; Kavallaris M
Cancer Res; 2010 Jun; 70(12):4995-5003. PubMed ID: 20501838
[TBL] [Abstract][Full Text] [Related]
25. Characterization of nuclear betaII-tubulin in tumor cells: a possible novel target for taxol.
Xu K; Ludueña RF
Cell Motil Cytoskeleton; 2002 Sep; 53(1):39-52. PubMed ID: 12211114
[TBL] [Abstract][Full Text] [Related]
26. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer.
Bessho Y; Oguri T; Ozasa H; Uemura T; Sakamoto H; Miyazaki M; Maeno K; Sato S; Ueda R
Oncol Rep; 2009 Jan; 21(1):263-8. PubMed ID: 19082471
[TBL] [Abstract][Full Text] [Related]
27. Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry.
Verdier-Pinard P; Wang F; Burd B; Angeletti RH; Horwitz SB; Orr GA
Biochemistry; 2003 Oct; 42(41):12019-27. PubMed ID: 14556633
[TBL] [Abstract][Full Text] [Related]
28. Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.
Mozzetti S; Ferlini C; Concolino P; Filippetti F; Raspaglio G; Prislei S; Gallo D; Martinelli E; Ranelletti FO; Ferrandina G; Scambia G
Clin Cancer Res; 2005 Jan; 11(1):298-305. PubMed ID: 15671559
[TBL] [Abstract][Full Text] [Related]
29. Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol.
Kavallaris M; Burkhart CA; Horwitz SB
Br J Cancer; 1999 Jun; 80(7):1020-5. PubMed ID: 10362110
[TBL] [Abstract][Full Text] [Related]
30. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
31. beta-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells.
Gökmen-Polar Y; Escuin D; Walls CD; Soule SE; Wang Y; Sanders KL; Lavallee TM; Wang M; Guenther BD; Giannakakou P; Sledge GW
Cancer Res; 2005 Oct; 65(20):9406-14. PubMed ID: 16230404
[TBL] [Abstract][Full Text] [Related]
32. Expression of class III beta-tubulin reduces microtubule assembly and confers resistance to paclitaxel.
Hari M; Yang H; Zeng C; Canizales M; Cabral F
Cell Motil Cytoskeleton; 2003 Sep; 56(1):45-56. PubMed ID: 12905530
[TBL] [Abstract][Full Text] [Related]
33. [Technetium-99m labeled synaptotagmin I C2A detection of paclitaxel-induced apoptosis in non-small cell lung cancer].
Wang F; Fang W; Ji SD; Meng QL; Li Y; Fan KW; Wang ZZ
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):351-4. PubMed ID: 17892130
[TBL] [Abstract][Full Text] [Related]
34. The tubulin-depolymerising agent combretastatin-4 induces ectopic aster assembly and mitotic catastrophe in lung cancer cells H460.
Cenciarelli C; Tanzarella C; Vitale I; Pisano C; Crateri P; Meschini S; Arancia G; Antoccia A
Apoptosis; 2008 May; 13(5):659-69. PubMed ID: 18386182
[TBL] [Abstract][Full Text] [Related]
35. Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability.
Poruchynsky MS; Kim JH; Nogales E; Annable T; Loganzo F; Greenberger LM; Sackett DL; Fojo T
Biochemistry; 2004 Nov; 43(44):13944-54. PubMed ID: 15518543
[TBL] [Abstract][Full Text] [Related]
36. Expression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer.
Okuda K; Sasaki H; Dumontet C; Kawano O; Yukiue H; Yokoyama T; Yano M; Fujii Y
Lung Cancer; 2008 Oct; 62(1):105-12. PubMed ID: 18395930
[TBL] [Abstract][Full Text] [Related]
37. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes.
Derry WB; Wilson L; Khan IA; Luduena RF; Jordan MA
Biochemistry; 1997 Mar; 36(12):3554-62. PubMed ID: 9132006
[TBL] [Abstract][Full Text] [Related]
38. Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins.
Tommasi S; Mangia A; Lacalamita R; Bellizzi A; Fedele V; Chiriatti A; Thomssen C; Kendzierski N; Latorre A; Lorusso V; Schittulli F; Zito F; Kavallaris M; Paradiso A
Int J Cancer; 2007 May; 120(10):2078-85. PubMed ID: 17285590
[TBL] [Abstract][Full Text] [Related]
39. Establishment and characterization of a paclitaxel-resistant human non-small cell lung cancer cell line.
Chu JJ; Chiang CD; Rao CS; Chang WM; Lai YK
Anticancer Res; 2000; 20(4):2449-56. PubMed ID: 10953309
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of human colon cancer cells changes the expression of beta-tubulin isotypes and MAPs.
Carles G; Braguer D; Dumontet C; Bourgarel V; Gonçalves A; Sarrazin M; Rognoni JB; Briand C
Br J Cancer; 1999 Jun; 80(8):1162-8. PubMed ID: 10376967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]